{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:46:38Z","timestamp":1790552798628,"version":"4.1.0"},"reference-count":21,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5,1]]},"abstract":"<jats:p>BACKGROUND. The introduction of highly active antiretroviral therapy for HIV led to significant declines in HIV-associated morbidity and mortality in children. Nonadherence to antiretroviral therapy is the leading cause of treatment failure in HIV-infected patients. The ability to recognize nonadherence is suboptimal, and differentiating it from other causes of inadequate viral suppression may be difficult.<\/jats:p><jats:p>OBJECTIVES. The purpose of this work was to examine the efficacy of hospital-based directly observed therapy in assessing adherence to antiretroviral medications in HIV-infected children and adolescents suspected of nonadherence and failing other interventions.<\/jats:p><jats:p>METHODS. The medical charts of all HIV-infected patients admitted to the University of Chicago Comer Children's Hospital for directly observed therapy from July 2004 to June 2006 were reviewed. Patients were hospitalized for 7 days. Data collected included demographics, clinical and immune class category, previous and current antiretroviral medications, viral resistance tests, HIV-1 RNA viral load, and CD4+ T-cell number and percentage before and after directly observed therapy.<\/jats:p><jats:p>RESULTS. There were 9 perinatally infected patients with a total of 13 admissions. The median age was 13 years, and 8 had been treated with multiple antiretroviral regimens. Three common patterns of changes in the viral load over time were observed. In the first, the viral load dropped at the end of the directly observed therapy period and stayed low thereafter. In the second, the drop in the viral load seen at the end of the period was not sustained. In the third, there was no change in the viral load during or after the directly observed therapy period. Compared with the viral load at admission, the viral load at the end of directly observed therapy was lower in 8 patients with a mean \u00b1 SD decrease of 0.8 \u00b1 0.55 log10 copies per mL.<\/jats:p><jats:p>CONCLUSIONS. Short, hospital-based directly observed therapy was helpful in confirming nonadherence to antiretroviral medications, therefore impacting future therapeutic decisions in HIV-infected children and adolescents. Short, hospital-based directly observed therapy should be considered in patients with poor virological control for whom outpatient interventions have failed.<\/jats:p>","DOI":"10.1542\/peds.2006-2614","type":"journal-article","created":{"date-parts":[[2007,4,24]],"date-time":"2007-04-24T16:31:35Z","timestamp":1177432295000},"page":"e1142-e1148","source":"Crossref","is-referenced-by-count":22,"title":["Hospital-Based Directly Observed Therapy for HIV-Infected Children and Adolescents to Assess Adherence to Antiretroviral Medications"],"prefix":"10.1542","volume":"119","author":[{"given":"Daniel","family":"Glikman","sequence":"first","affiliation":[{"name":"Pediatric and Adolescent HIV Program, Section of Infectious Diseases, Department of Pediatrics, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Walsh","sequence":"additional","affiliation":[{"name":"Pediatric and Adolescent HIV Program, Section of Infectious Diseases, Department of Pediatrics, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Valkenburg","sequence":"additional","affiliation":[{"name":"Pediatric and Adolescent HIV Program, Section of Infectious Diseases, Department of Pediatrics, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Daisy","family":"Mangat","sequence":"additional","affiliation":[{"name":"Pediatric and Adolescent HIV Program, Section of Infectious Diseases, Department of Pediatrics, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Marcinak","sequence":"additional","affiliation":[{"name":"Pediatric and Adolescent HIV Program, Section of Infectious Diseases, Department of Pediatrics, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2007,5,1]]},"reference":[{"key":"2021120823340436500_R1","doi-asserted-by":"crossref","unstructured":"Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med.\u20081998;338:853\u2013860","DOI":"10.1056\/NEJM199803263381301"},{"key":"2021120823340436500_R2","doi-asserted-by":"crossref","unstructured":"Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA.\u20081998;279:450\u2013454","DOI":"10.1001\/jama.279.6.450"},{"key":"2021120823340436500_R3","doi-asserted-by":"crossref","unstructured":"Descamps D, Flandre P, Calvez V, et al. Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. JAMA.\u20082000;283:205\u2013211","DOI":"10.1001\/jama.283.2.205"},{"key":"2021120823340436500_R4","doi-asserted-by":"crossref","unstructured":"Reddington C, Cohen J, Baldillo A, et al. Adherence to medication regimens among children with human immunodeficiency virus infection. Pediatr Infect Dis J.\u20082000;19:1148\u20131153","DOI":"10.1097\/00006454-200012000-00005"},{"key":"2021120823340436500_R5","doi-asserted-by":"crossref","unstructured":"Watson DC, Farley JJ. Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. Pediatr Infect Dis J.\u20081999;18:682\u2013689","DOI":"10.1097\/00006454-199908000-00006"},{"key":"2021120823340436500_R6","doi-asserted-by":"crossref","unstructured":"Ickovics JR, Cameron A, Zackin R, et al. Consequences and determinants of adherence to antiretroviral medication: results from Adult AIDS Clinical Trials Group Protocol 370. Antivir Ther.\u20082002;7:185\u2013193","DOI":"10.1177\/135965350200700308"},{"key":"2021120823340436500_R7","doi-asserted-by":"crossref","unstructured":"Osterberg L, Blaschke T. Adherence to medication. N Engl J Med.\u20082005;353:487\u2013497","DOI":"10.1056\/NEJMra050100"},{"key":"2021120823340436500_R8","doi-asserted-by":"crossref","unstructured":"Shingadia D, Viani RM, Yogev R, et al. Gastrostomy tube insertion for improvement of adherence to highly active antiretroviral therapy in pediatric patients with human immunodeficiency virus. Pediatrics.\u20082000;105(6). Available at: www.pediatrics.org\/cgi\/content\/full\/105\/6\/e80","DOI":"10.1542\/peds.105.6.e80"},{"key":"2021120823340436500_R9","doi-asserted-by":"crossref","unstructured":"Roberts GM, Wheeler JG, Tucker NC, et al. Nonadherence with pediatric human immunodeficiency virus therapy as medical neglect. Pediatrics.\u20082004;114:346\u2013353","DOI":"10.1542\/peds.2003-0588-F"},{"key":"2021120823340436500_R10","unstructured":"Simoni JM, Frick PA, Pantalone DW, Turner BJ. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med.\u20082003;11:185\u2013198"},{"key":"2021120823340436500_R11","doi-asserted-by":"crossref","unstructured":"Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis: consensus statement of the public health tuberculosis guidelines panel. JAMA.\u20081998;279:943\u2013948","DOI":"10.1001\/jama.279.12.943"},{"key":"2021120823340436500_R12","doi-asserted-by":"crossref","unstructured":"Mitty JA, Stone VE, Sands M, Macalino G, Flanigan T. Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress. Clin Infect Dis.\u20082002;34:984\u2013990","DOI":"10.1086\/339447"},{"key":"2021120823340436500_R13","doi-asserted-by":"crossref","unstructured":"Mitty JA, Flanigan TP. Community-based interventions for marginalized populations. Clin Infect Dis.\u20082004;38:S373\u2013S375","DOI":"10.1086\/421398"},{"key":"2021120823340436500_R14","doi-asserted-by":"crossref","unstructured":"Gigliotti F, Murante BL, Weinberg GA. Short course directly observed therapy to monitor compliance with antiretroviral therapy in human immunodeficiency virus-infected children. Pediatr Infect Dis J.\u20082001;20:716\u2013718","DOI":"10.1097\/00006454-200107000-00017"},{"key":"2021120823340436500_R15","doi-asserted-by":"crossref","unstructured":"Parsons GN, Siberry GK, Parsons JK, et al. Multidisciplinary, inpatient directly observed therapy for HIV-1-infected children and adolescents failing HAART: a retrospective study. AIDS Patient Care STDS.\u20082006;20:275\u2013284","DOI":"10.1089\/apc.2006.20.275"},{"key":"2021120823340436500_R16","unstructured":"US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Available at: http:\/\/aidsinfo.nih.gov. Accessed August 10, 2006"},{"key":"2021120823340436500_R17","doi-asserted-by":"crossref","unstructured":"Bartlett JA, DeMasi R, Dawson D, Hill A. Variability in repeated consecutive measurements of plasma human immunodeficiency virus RNA in persons receiving stable nucleoside reverse transcriptase inhibitor therapy or no treatment. J Infect Dis.\u20081998;178:1803\u20131805","DOI":"10.1086\/314503"},{"key":"2021120823340436500_R18","doi-asserted-by":"crossref","unstructured":"Flynn PM, Rudy BJ, Douglas SD, et al. Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy. J Infect Dis.\u20082004;190:271\u2013279","DOI":"10.1086\/421521"},{"key":"2021120823340436500_R19","doi-asserted-by":"crossref","unstructured":"Palumbo PE, Raskino C, Fiscus S, et al. Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children. JAMA.\u20081998;279:756\u2013761","DOI":"10.1001\/jama.279.10.756"},{"key":"2021120823340436500_R20","doi-asserted-by":"crossref","unstructured":"Gibb DM, Duong T, Leclezio VA, Walker AS, Verweel G, Dunn DT. Immunologic changes during unplanned treatment interruptions of highly active antiretroviral therapy in children with human immunodeficiency virus type 1 infection. Pediatr Infect Dis J.\u20082004;23:446\u2013450","DOI":"10.1097\/01.inf.0000122601.62358.74"},{"key":"2021120823340436500_R21","doi-asserted-by":"crossref","unstructured":"Borkowsky W, Stanley K, Douglas SD, et al. Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children. J Infect Dis.\u20082000;182:96\u2013103","DOI":"10.1086\/315672"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/119\/5\/e1142\/1118965\/zpe005070e1142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/119\/5\/e1142\/1118965\/zpe005070e1142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T15:11:04Z","timestamp":1683817864000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/119\/5\/e1142\/70226\/Hospital-Based-Directly-Observed-Therapy-for-HIV"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,1]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,5,1]]},"published-print":{"date-parts":[[2007,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-2614","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,1]]}}}